1. EPIX Therapuetics designs and manufactures a catheter-based, temperature-controlled cardiac ablation system for patients with irregular heartbeats and atrial fibrillation.
2. When completed, the acquisition will expand Medtronic’s cardiac ablation portfolio to offer physicians a comprehensive suite of tools to treat patients with cardiac arrhythmias.
3. The acquisition is expected to close in Medtronic’s fourth quarter, which runs Jan. 26 to April 26.
More articles on devices and implants:
DePuy Synthes releases femoral neck fixation solution: 4 things to know
ZAP Surgical launches radiosurgery platform at Barrow Brain and Spine: 3 details
X-Bolt hip fracture device receives FDA approval: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
